Compare BMRN & WSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BMRN | WSO |
|---|---|---|
| Founded | 1996 | 1945 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.0B | 13.6B |
| IPO Year | 1999 | 1994 |
| Metric | BMRN | WSO |
|---|---|---|
| Price | $66.53 | $315.13 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 18 | 6 |
| Target Price | $88.22 | ★ $399.00 |
| AVG Volume (30 Days) | ★ 2.2M | 478.0K |
| Earning Date | 05-04-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 3.08% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.77 | ★ 5.92 |
| Revenue | $1,313,646,000.00 | ★ $7,239,290,000.00 |
| Revenue This Year | $15.02 | $3.02 |
| Revenue Next Year | $12.23 | $5.20 |
| P/E Ratio | $86.55 | ★ $53.16 |
| Revenue Growth | ★ 17.62 | N/A |
| 52 Week Low | $49.26 | $295.75 |
| 52 Week High | $70.98 | $459.00 |
| Indicator | BMRN | WSO |
|---|---|---|
| Relative Strength Index (RSI) | 56.83 | 44.23 |
| Support Level | $58.03 | $301.25 |
| Resistance Level | $70.98 | $323.89 |
| Average True Range (ATR) | 1.56 | 9.15 |
| MACD | -0.34 | 2.45 |
| Stochastic Oscillator | 46.31 | 67.43 |
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
Watsco is the largest HVAC and refrigeration products distributor in North America with approximately 13% market share. The company primarily operates in the United States (90% of revenue) with significant exposure in the Sunbelt states. Watsco also has operations in Canada, Latin America, and the Caribbean. The company's customer base comprises more than 120,000 dealers and contractors serving the replacement and new-construction HVAC/R markets for residential and light-commercial applications. As much as 20% of residential HVAC units are distributed through Watsco in any given year. Revenue is approximately 75%-80% residential HVAC and 20%-25% commercial, with relatively small exposure to more complex "applied" solutions.